Your browser doesn't support javascript.
loading
'How much raltegravir do you take?' The answer may not be so obvious: an accidental finding from clinical practice.
Emiliozzi, Arianna; Ciccullo, Arturo; Borghetti, Alberto; Picarelli, Chiara; Farinacci, Damiano; Baldin, Gianmaria; Di Giambenedetto, Simona.
Afiliação
  • Emiliozzi A; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy.
  • Ciccullo A; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy.
  • Borghetti A; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Malattie Infettive, Rome, Italy.
  • Picarelli C; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy.
  • Farinacci D; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy.
  • Baldin G; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy.
  • Di Giambenedetto S; Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy.
HIV Med ; 21(2): e1-e2, 2020 02.
Article em En | MEDLINE | ID: mdl-31338932

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Adesão à Medicação / Raltegravir Potássico Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Adesão à Medicação / Raltegravir Potássico Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article